32
Participants
Start Date
December 31, 2005
Primary Completion Date
January 31, 2007
Study Completion Date
March 31, 2010
Pemetrexed
Given intravenously over 10 minutes every 21 days (21 days equals one cycle). Subjects will continue to receive pemetrexed as long as their disease does not worsen and they do not experience any serious side effects.
Dana-Farber Cancer Center, Boston
Beth Israel Deaconess Medical Center
OTHER
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Dana-Farber Cancer Institute
OTHER